Aimmune Therapeutics, Inc. is a biopharmaceutical company developing a therapeutic approach and product candidates for the treatment of peanut and other food allergies.
Also known as
AIMT
Relationship register
4 documented relationships
Documented relationships
4 documented relationships
Hover or select an entity to isolate its relationships. Link thickness reflects the documented amount.Detailed register
Amount not specifiedReported1Aimmune Therapeutics, Inc.: Shareholders Board Members Managers and Company Profile | US00900T1079 | MarketScreener Canadaca.marketscreener.com3Aimmune Therapeutics, Inc.: Shareholders Board Members Managers and Company Profile | US00900T1079 | MarketScreener Canadaca.marketscreener.com4Aimmune Therapeutics, Inc.: Shareholders Board Members Managers and Company Profile | US00900T1079 | MarketScreener UKuk.marketscreener.com
Function or object indicated by the source: “subsidiary”.
Amount not specifiedReported1Aimmune Therapeutics, Inc.: Shareholders Board Members Managers and Company Profile | US00900T1079 | MarketScreener Canadaca.marketscreener.com
Position or role indicated by the source: “subsidiary”.